SEC Form 4 · accession 0001209191-17-001827
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marc Belsky
Officer — Senior Vice President and CFO
Period of report
Jan 3, 2017
Accepted (ET)
Jan 5, 2017 · 2:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 3, 2017 | F | 2,281 | $48.60 | D | 65,666 | I | By the Belsky Living Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Since the date of the reporting person's last ownership report, he transferred 67,947 shares of common stock to the Belsky Living Trust.